PROK

PROKIDNEY CORP

PROK·74291D104·US·Common Stock·Healthcare - Biotechnology-Activist

PROK (PROKIDNEY CORP) is held by 42 institutional investors as of Q1 2026. Largest holders: MORGAN STANLEY ($16M), MILLENNIUM MANAGEMENT LLC ($4.1M), BlackRock, Inc. ($2.5M). Net institutional sentiment: Mixed.

42
Holders
Avg rating(7 Elite)
$42M
Total Value
53% (46)
Fund Consensus
21 buying - 19 selling
PROKSmart Money Verdict
View all
Held by 42 funds
7 elite
Who's Trading
ActivistCSCarlos Slim Helu36.0%Apr 30, 2026
InsiderCCControl Empresarial de Capitales S.A. de C.V.C 63.1M shApr 28, 2026
ActivistMorgan StanleyMorgan Stanley6.0%Feb 12, 2026
InsiderPJPereira Brian JGSell $1.1MNov 13, 2025
InsiderPJPereira Brian JGSell $129KNov 13, 2025
InsiderPJPereira Brian JGSell $619KNov 12, 2025
InsiderPJPereira Brian JGSell $75KNov 12, 2025
ActivistMorgan StanleyMorgan Stanley4.4%Aug 7, 2025
ActivistBlackRock, Inc.BlackRock, Inc.1.4%Jul 17, 2025
InsiderWJWeber Darin J.Sell $313KJul 8, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
9M(+1.6%)$16M0.0%-27.00%
29
Increased
2.3M(+23.8%)$4.1M0.0%-27.52%
32
Decreased
1.4M(-1.2%)$2.5M0.0%-28.30%
0
Increased
1.3M(+39.6%)$2.2M0.0%-21.16%
34
Increased
1.2M(+2.8%)$2.2M0.0%-28.16%
27
New
1.1M$2.1M0.0%-20.36%
36
Increased
1M(+65.2%)$1.8M0.0%-15.43%
38
Increased
753,412(+6.7%)$1.3M0.0%-28.05%
27
Increased
627,771(+0.8%)$1.1M0.0%-28.97%
25
Increased
556,845(+15.9%)$996,7530.0%-27.87%
20
New
538,371$963,6840.0%-20.36%
35
Unchanged
500,000$895,0000.0%-20.00%
0
Decreased
421,902(-38.1%)$755,2040.0%-22.39%
0
Decreased
346,382(-25.6%)$620,0240.0%-22.11%
0
Decreased
334,546(-19.7%)$598,8370.0%-29.03%
0
Increased
291,708(+7.2%)$522,1570.0%-20.03%
26
Decreased
264,285(-46.5%)$473,0700.0%-21.40%
0
Increased
254,353(+97.4%)$455,2920.0%-24.15%
38
Unchanged
241,580$432,4280.0%-27.28%
0
Decreased
211,107(-39.9%)$377,8820.0%-28.87%
0

Showing 1-20 of 46

1 / 3

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used